Response-Guided Neoadjuvant Chemo Beneficial in Breast CA A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ...
A multicenter American College of Radiology Imaging Network trial has determined that breast lesions categorized as BI-RADS 3 or probably benign have low malignancy rates, suggesting that follow-up ...
OAK BROOK, Ill. – Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound ...
OAK BROOK, Ill. - Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that ...
Expression of GHRH-R in primary and metastatic mammary carcinomas. This is an ASCO Meeting Abstract from the 2014 Breast Cancer Symposium. This abstract does not include a full text component.
Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing The Breast Imaging Reporting and Data System (BI-RADS) lexicon ...
(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results